• CD38 CAR Binder Structure and Affinity Tuning

  2026-08-22

  This iScience study defines how two CD38-targeting CAR binders engage distinct antigen surfaces and couple binding geometry to enzymatic inhibition, fratricide, and tumor-cell killing. Its structure-guided analysis supports a more nuanced approach to CAR optimization in which affinity, epitope, catalytic modulation, and cellular selectivity are tuned together rather than treated as independent variables.

• SMPD4, Ceramide, and Primary Cilia in Brain Development

  2026-08-22

  The 2024 Development study identifies SMPD4-dependent ceramide production as a mechanistic link between sphingolipid metabolism, primary-cilium formation, neural progenitor survival, and brain development. By combining a mouse model with SMPD4-deficient human induced pluripotent stem cells and a ceramide-rescue experiment, the work clarifies how SMPD4 variants may cause microcephaly and cerebellar hypoplasia.

• NF90, AGEs, and Diabetic Atherosclerotic Calcification

  2026-08-21

  This Nature Communications study identifies smooth muscle NF90/110 as a mechanistic link between advanced glycation end products and diabetic atherosclerotic calcification. Using male mouse models, vascular smooth muscle cell experiments, and human calcified samples, the authors define an NF90–FBXW7–AGER1 axis that may be useful for studying calcification, apoptosis, and AGE handling in diabetic vascular disease.

• Neurotensin Workflows for GPCR Trafficking

  2026-08-20

  Build time-resolved assays around Neurotensin as a Neurotensin receptor 1 activator to connect receptor recycling with miR-133α modulation. This practical guide combines peptide handling, trafficking and miRNA readouts, plus cautious fluorescence-processing strategies adapted from a recent spectral-classification study.

• Trelagliptin, PI3K/AKT, and Adipocyte Insulin Resistance

  2026-08-20

  The reference study links trelagliptin succinate exposure with improved insulin signaling, GLUT4 translocation, and glucose uptake in differentiated 3T3-L1 adipocytes. Its innovation is the integration of phosphorylation-related signaling measurements with adipokine and free-fatty-acid readouts, while the in vitro model limits direct clinical and causal interpretation.

• CD44, Copper, and Ly6Chi Macrophages in Colitis

  2026-08-19

  The reference study identifies a mechanistic connection between CD44 upregulation, intracellular copper accumulation, and activation of inflammatory Ly6Chi macrophages in ulcerative colitis. Its combination of single-cell analysis, pharmacological intervention, proteomics, and macrophage experiments suggests that copper handling and oxidative stress are important links between macrophage state and intestinal inflammation.

• EZ Cap™ EGFP mRNA (5-moUTP) for Assays

  2026-08-19

  This scenario-driven guide explains how EZ Cap™ EGFP mRNA (5-moUTP), SKU R1016, can improve interpretation of viability, proliferation, cytotoxicity, and delivery experiments. It links transcript design, handling, controls, and vendor selection to practical laboratory decisions.

• Tunicamycin B7417 for Reliable ER-Stress Assays

  2026-08-18

  A scenario-based guide to using Tunicamycin (SKU B7417) as a N-glycosylation inhibitor in cell viability, proliferation, cytotoxicity, and macrophage inflammation workflows. It explains mechanism, protocol controls, interpretation of GRP78, COX-2, and iNOS data, and practical criteria for selecting a reliable research reagent.

• Deep Learning for iPSC-CM Cardiotoxicity Screening

  2026-08-18

  Grafton and colleagues developed a high-content screening workflow that combines induced pluripotent stem cell-derived cardiomyocytes with deep-learning image analysis to identify cardiotoxic phenotypes. The study shows how a single phenotypic score can prioritize liabilities across mechanistically diverse compounds and support earlier safety decisions in drug discovery.

• AG-221 Enasidenib Workflow for IDH2 AML

  2026-08-17

  Build a translational IDH2-mutant AML workflow around AG-221 (Enasidenib), linking oncometabolite suppression with differentiation and metabolic-dependency assays. Practical dosing, sample-handling, CD44-focused readouts, and troubleshooting guidance help distinguish target engagement from nonspecific loss of viability.

• From Pheromone Biology to High-Fidelity PCR

  2026-08-17

  A translational framework connecting pheromone-driven neurodegeneration in C. elegans with rigorous PCR strategy, highlighting how a proofreading DNA polymerase can improve sequence confidence in mechanistic, cloning, genotyping, and sequencing workflows.

• Nocodazole: Metabolism Meets Microtubule Dynamics

  2026-08-16

  Nocodazole is more than a mitotic arrest reagent. By pairing reversible β-tubulin perturbation with emerging evidence on HDAC6-catalyzed α-tubulin lactylation, translational researchers can build sharper experiments connecting metabolism, cytoskeletal plasticity, cell-cycle control, and anticancer drug evaluation.

• 5-Aminolevulinic Acid HCl in Infection Biology

  2026-08-15

  Discover how 5-Aminolevulinic acid HCl can be used as a pathway-perturbation reagent in heme and host–pathogen research. This article translates recent Salmonella findings into practical assay decisions while distinguishing precursor rescue from genetic control of virulence.

• Osteoblast ECM1 Drives Anti-Androgen Resistance in Bone PCa

  2026-08-14

  The reference study identifies osteoblast-derived ECM1 as a microenvironmental driver of enzalutamide resistance in bone metastatic prostate cancer. Its mechanistic model links ECM1 to membrane-associated ENO1, ENO1 Y189 phosphorylation, GRB2–SOS1 recruitment, and MAPK activation, while ECM1 blockade or ENO1 inhibition restores drug sensitivity.

• HyperScribe T7 High Yield RNA Synthesis Kit Guide

  2026-08-14

  Build high-output RNA workflows for capped, labeled, biotinylated, and modified transcripts with a defined 20 μL transcription format. The kit also provides a practical route to assay controls for RNA vaccine research, RNA interference experiments, and antibody-based epitranscriptomic studies.

523 records 6/35 page Previous Next First page 上5页 678910 下5页 Last page